Alergo-Med Specjalistyczna Przychodnia Lekarska Sp. z o.o.

The medical center is at the forefront of dermatology research, focusing on innovative treatments for atopic dermatitis. Through extensive clinical trials, the center is exploring the efficacy of novel therapies such as SAR444656, eblasakimab, and abrocitinib, aiming to improve patient outcomes in moderate to severe cases.

• Atopic Dermatitis
• Chronic Urticaria
• Vitiligo
• Prurigo Nodularis

These studies contribute significantly to understanding the long-term safety and effectiveness of emerging treatments, offering hope for enhanced quality of life for patients.

Specializing in respiratory medicine, the center conducts pivotal research on conditions such as asthma and respiratory syncytial virus (RSV). Trials involving CHF5993 and EDP-938 are designed to assess new therapeutic approaches, focusing on safety and efficacy in managing these complex conditions.

• Asthma
• Respiratory Syncytial Virus (RSV)
• Recurrent Wheezing
• Chronic Cough

The center's research is instrumental in developing advanced inhalation therapies and antiviral treatments, aiming to reduce exacerbations and improve respiratory health.

In the field of allergy and immunology, the center is pioneering studies on allergic rhinitis and related conditions. Investigations into treatments like lebrikizumab and mannan-conjugated birch pollen allergoids are underway to enhance therapeutic strategies for managing allergic responses.

• Allergic Rhinitis
• Rhinoconjunctivitis
• Perennial Allergic Rhinitis

These efforts are crucial in advancing our understanding of immune system modulation and improving patient care in allergic diseases.